Displaying 21 - 40 of 249 results

Study Identifies Subtypes of Inflammation in People with Rheumatoid Arthritis

https://www.niams.nih.gov/newsroom/spotlight-on-research/study-identifies-subtypes-inflammation-people-rheumatoid-arthritis

Rheumatoid arthritis (RA) is an autoimmune disease that causes joint inflammation, pain, and stiffness. There are several treatment options to control inflammation, but response to therapy varies and some people with RA never reach remission, suggesting there may be different drivers of inflammation.

Piecing Together the Puzzle of Chronic Low Back Pain

https://www.niams.nih.gov/piecing-together-puzzle-chronic-low-back-pain

The human back is a complex structure with bones, nerves, tendons, discs, and more — all places where something can go wrong and cause pain, which, for many people, becomes a long-term or chronic problem. Life stresses and other medical and mental health conditions aggravate the problem. With so many pieces, it’s hard to get a holistic view of the puzzle or pinpoint the cause of the pain. “People tend to focus on one aspect or another,” said Jeffrey Lotz, Ph.D., a medical engineer who studies back pain at the University of California, San Francisco. “Some people think it’s largely

Array of Patient Recruitment Efforts Boost Back Pain Study Participation

https://www.niams.nih.gov/newsroom/spotlight-on-research/array-patient-recruitment-efforts-boost-back-pain-study

Back pain is one of the most common forms of chronic pain affecting adults. People with chronic back pain often take opioids for pain management, but opioids are highly addictive. To address this public health challenge, in 2019 NIH launched the Back Pain Consortium (BACPAC) Research Program, part of the NIH Helping to End Addiction Long-term® (HEAL) Initiative that launched in 2018, a patient-centered effort to address the need for non-addictive, effective and personalized therapies for chronic back pain. Scientists are conducting clinical trials with the hopes of finding new non-opioid treatments. Yet for clinical trials to be effective, the

Conquering Low Back Pain: Finding the Best Treatment for Individual Patients

https://www.niams.nih.gov/newsroom/spotlight-on-research/conquering-low-back-pain-finding-best-treatment-individual-patients

The HEAL-funded Biomarkers for Evaluating Spine Treatments (BEST) clinical trial is taking an innovative approach. This large collaborative study – developed by the Back Pain Consortium (BACPAC) Research Program – aims to learn what back pain treatment or sequence of treatments are most effective for people based on their unique traits.

Weight loss and exercise to improve rheumatoid arthritis cardiovascular risk

https://www.niams.nih.gov/grants-funding/clinical-trials-spotlight/weight-loss-and-exercise-improve-rheumatoid-arthritis

Clinical Trials in the Spotlight Main Page The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) supports a range of clinical trials studying new and existing interventions for prevention and treatment of arthritis, musculoskeletal, and skin diseases. Investigators supported by the NIAMS need your help finding individuals to

NIAMS, NIH Seek to Better Understand Arthritis in Native American Communities

https://www.niams.nih.gov/about/about-the-director/letter/niams-nih-seek-to-better-understand-arthritis-in-native-american-communities

The recent observance in May of National Arthritis Awareness Month offered us a chance to reflect on a sizable component of the NIAMS mission area. Arthritis impacts the lives of nearly 60 million Americans. However, a recent conversation with David Wilson, Ph.D., director of NIH’s Tribal Health Research Office, reminded me that arthritis hits some communities harder than others.

Typically materials from NIAMS that are more than 5 years old will be archived.